NCT04846179View on ClinicalTrials.gov

To Evaluate the Effect of Ginkgo Biloba Extract on Optic Nerve Head Perfusion Examined Using OCTA

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions

Glaucoma

Interventions

DIETARY_SUPPLEMENT

Ginkgo biloba extract

Patients recruited to Ginkgo Biloba Extract (GBE) group will be advised to take Webber Natural Ginkgo Biloba 120 mg soft gel, 1 tablet twice a day for 4 months.

Trial Locations (1)

B3H 4R2

Nova Scotia Health, Halifax

All Listed Sponsors

lead

Nova Scotia Health Authority

OTHER